| Date Filed | Type | Description |
| 08/17/2023 |
SC 13D
| Caligan Partners LP reports a 6.2% stake in Anika Therapeutics, Inc. |
| 08/03/2023 |
SC 13D/A
| Caligan Partners LP reports a 33.1% stake in Alimera Sciences, Inc. |
| 07/03/2023 |
SC 13D/A
| Caligan Partners LP reports a 9.9% stake in Standard BioTools, Inc. |
| 06/02/2023 |
SC 13D/A
| Caligan Partners LP reports a 0.3% stake in Exelixis, Inc. |
| 05/18/2023 |
SC 13D/A
| Caligan Partners LP reports a 10% stake in Alimera Sciences, Inc. |
| 03/28/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/27/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/20/2023 |
SC 13D
| Caligan Partners LP reports a 0.3% stake in Exelixis, Inc. |
| 12/30/2022 |
SC 13D/A
| Caligan Partners LP reports a 10.8% stake in Standard BioTools, Inc. |
| 12/09/2022 |
SC 13D/A
| Caligan Partners LP reports a 4.6% stake in ADMA Biologics, Inc. |
| 08/05/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/07/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/25/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 05/03/2022 |
SC 13D/A
| Caligan Partners LP reports a 12.3% stake in Standard BioTools, Inc. |
| 03/29/2022 |
SC 13D/A
| Caligan Partners LP reports a 10.9% stake in Fluidigm Corporation |
| 12/07/2021 |
SC 13D/A
| Caligan Partners LP reports a 13.9% stake in Liquidia Corporation |
| 04/15/2021 |
SC 13D
| Caligan Partners LP reports a 16.1% stake in Liquidia Corporation |
| 11/16/2020 |
SC 13D/A
| Caligan Partners LP reports a 0% stake in AMAG Pharmaceuticals, Inc. |
| 10/10/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/30/2019 |
SC 13D/A
| Caligan Partners LP reports a 4.7% stake in Knowles Corporation |
| 09/04/2019 |
SC 13D/A
| Caligan Partners LP reports a 10.3% stake in AMAG Pharmaceuticals, Inc. |
| 08/15/2019 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 05/09/2019 |
SC 13D/A
| Caligan Partners LP reports a 5.1% stake in Knowles Corporation |
| 03/11/2019 |
SC 13D
| Caligan Partners LP reports a 4.4% stake in Knowles Corporation |